In 2016, tuberculosis (TB) was declared the world’s most infectious disease by the World Health Organisation (WHO). Today, it is classified as a Global Health Emergency, ranking above HIV in terms of mortality. Negligence, even in more developed countries, has led us to this point and now the race is on to treat this disease.
Million TB-related deaths globally in 2016
Billion spent on existing TB interventions
Of the world’s population is infected with TB
The solution to TB lies in prevention rather than cure. SRS is pioneering products that suppress TB manifestation.
The mission is to eradicate tuberculosis (TB) by reducing people’s risk of developing the infection with a unique, revolutionary product (Nyaditum
resae®) based on the most updated technology and a solid scientific foundations.
Critically, we do not compete with any existing antibiotics with respect to curing TB. And, the product is delivered in the form of food, which has a short duration, allowing the generation of a balanced immune response in the patient.
As part of our ongoing fight against this disease, we continue to explore novel, evidence-based products and concepts; working with like-minded inventors and partners to get the right treatments to the people in need, when they need them.